A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

Obstructive sleep apnea occurs when the upper airway repeatedly collapses during sleep, temporarily blocking airflow ...

The goal in the world of global health is to bring an end to this scourge by 2030. A new drug looks as if it could do the job ...

(Tim Kitchen/Getty Images) Sleeping with a clunky breathing machine is a problem for many with sleep apnea, but a more comfortable alternative is on the horizon. In a recent clinical drug trial that ...

Shionogi has struck a deal to take full control of its sleep disorder joint venture, agreeing to pay Apnim | Shionogi has ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of ...

The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday—marking a significant win for the drug company Eli Lilly, which had Zepbound ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to ...

WASHINGTON — Jazz Pharmaceuticals lost its bid to overturn the approval of another company’s rival sleep drug when a D.C. federal judge ruled that the FDA did not violate the Orphan Drug Act when ...

Vanda Pharmaceuticals’ seven-year ambition to score a coveted label expansion for sleep drug Hetlioz has taken an unusual turn, with the FDA acquiescing to a formal hearing on the matter. The ...

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage ...